CHTF8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.363230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.571800E-02
Normal-vs-Stage2
1.235170E-01
Normal-vs-Stage3
4.888200E-02
Normal-vs-Stage4
6.096600E-01
Stage1-vs-Stage2
5.681000E-01
Stage1-vs-Stage3
7.263600E-02
Stage1-vs-Stage4
2.581600E-01
Stage2-vs-Stage3
9.972100E-02
Stage2-vs-Stage4
5.884000E-03
Stage3-vs-Stage4
6.351900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.340040E-01
Normal-vs-AfricanAmerican
1.343790E-01
Normal-vs-Asian
1.135800E-01
Caucasian-vs-AfricanAmerican
4.961800E-01
Caucasian-vs-Asian
4.777400E-01
AfricanAmerican-vs-Asian
3.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.167180E-01
Normal-vs-Female
1.623630E-01
Male-vs-Female
7.036000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.322790E-01
Normal-vs-Age(41-60Yrs)
2.502600E-01
Normal-vs-Age(61-80Yrs)
9.582200E-02
Normal-vs-Age(81-100Yrs)
8.339500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.570600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.738200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.638200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.598600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.615200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.060000E-02
Normal-vs-Daily Drinker
5.784200E-02
Normal-vs-Weekly Drinker
6.132200E-02
Normal-vs-Occasional Drinker
5.157000E-01
Normal-vs-Social Drinker
1.743040E-01
Non Drinker-vs-Daily Drinker
8.268400E-01
Non Drinker-vs-Weekly Drinker
7.357400E-01
Non Drinker-vs-Occasional Drinker
3.464200E-02
Non Drinker-vs-Social Drinker
2.048400E-01
Daily Drinker-vs-Weekly Drinker
8.830000E-01
Daily Drinker-vs-Occasional Drinker
2.700000E-02
Daily Drinker-vs-Social Drinker
1.463560E-01
Weekly Drinker-vs-Occasional Drinker
3.942500E-02
Weekly Drinker-vs-Social Drinker
1.458170E-01
Occasional Drinker-vs-Social Drinker
4.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.823000E-01
Normal-vs-Grade 2
5.828800E-01
Normal-vs-Grade 3
5.174600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.018640E-01
Grade 1-vs-Grade 3
1.019930E-02
Grade 1-vs-Grade 4
2.823000E-01
Grade 2-vs-Grade 3
7.890400E-02
Grade 2-vs-Grade 4
5.828800E-01
Grade 3-vs-Grade 4
5.174600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.042200E-02
Normal-vs-NonDiabetic
1.025780E-01
Diabetic-vs-NonDiabetic
3.565400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.037040E-01
Normal-vs-NoPancreatitis
1.078400E-01
Pancreatitis-vs-NoPancreatitis
5.950800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.448830E-01
Normal-vs-N1
1.487220E-01
N0-vs-N1
8.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.038000E-01
Normal-vs-TP53-NonMutant
2.647600E-01
TP53-Mutant-vs-TP53-NonMutant
4.209600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
